| abstract |
The invention provides a therapeutic combination for use in the treatment of cachexia or of a maladaptive nutritional state secondary to a chronic Systemic Inflammatory Response State (SIRS), wherein the combination comprises at least one member of a first group and at least one member of a second group; nwherein members of the first group are selected from the group consisting of angiotensin receptor blockers (ARBs); and nmembers of the second group are selected from the group consisting of non-steroidal anti-inflammatory drugs (NSAIDs). |